The University of Dundee is to lead new research into a ‘forgotten cancer’ related to lifestyle and deprivation which Scots are more likely to be diagnosed with than almost any other group in the world. Russell Petty, Professor of Medical Oncology at the University’s School of Medicine, has received £300,000 from the Chief Scientist Office to try and overcome resistance to treatment experienced by oesophageal...
Aberdeen’s Scottish Biologics Facility (SBF) which has helped to spawn diagnostic and therapeutic approaches for diseases such as Alzheimer’s, cancer, arthritis and many more, has celebrated its 10th anniversary with a special event. The SBF at the University of Aberdeen started with a grant of around £90,000 but this has since grown to become a key cog in developing new therapies which are commercially viable....
In order to support the growing demand for its integrated drug discovery services, BioAscent Discovery Limited has announced the appointment of Julian Abery as Director of Business Development, North America. Mr Abery joins the BioAscent team as a consultant to drive the company’s continued growth into the expanding US market. Julian brings a wealth of knowledge and experience in the US-based pharma and biotech research market,...
Scientists have visualised for the first time protein ‘tangles’ associated with dementia in the brains of patients who have suffered a single head injury. This is the finding of a new study led by scientists from Imperial College London, published in the journal Science Translational Medicine. In the early-stage study, researchers studied 21 patients who had suffered a moderate to severe head injury at...
Edinburgh-based biotechnology company MedAnnex Ltd has received a further £1m investment from The Scottish Investment Bank (SIB), the investment arm of Scotland’s national economic development agency, Scottish Enterprise. This adds to a recent £10m Series B investment, by Boston-based global Life Sciences investor Morningside Ventures, to close an £11m funding round for MedAnnex. Please see here: https://www.scottish-enterprise-mediacentre.com/news/gbp-11m-boost-for-leading-scottish-antibody-development-company For further coverage, please see here: https://highgrowth.scot/2019/08/29/11-million-boost-for-scottish-antibody-development-company/...
Edinburgh-based biotechnology company MedAnnex Ltd has received a further £1m investment from The Scottish Investment Bank (SIB), the investment arm of Scotland’s national economic development agency, Scottish Enterprise. This adds to a recent £10m Series B investment, by Boston-based global Life Sciences investor Morningside Ventures, to close an £11m funding round for MedAnnex. MedAnnex is a privately-owned company founded by UK biotech entrepreneur Professor Chris...